CareDx Files 8-K on Financial Condition and Operations

TL;DR

**CareDx just dropped an 8-K on its financials and operations, so keep an eye out for details.**

AI Summary

CareDx, Inc. filed an 8-K on February 28, 2024, reporting on its results of operations and financial condition, along with a Regulation FD Disclosure. The filing indicates that the company, incorporated in Delaware with IRS Employer Identification No. 94-3316839, is located at 8000 Marina Boulevard, Brisbane, California 94005. This report is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Why It Matters

This filing provides an update on CareDx's financial health and operational performance, which can influence investor decisions and market perception of the company.

Risk Assessment

Risk Level: low — This 8-K is a standard disclosure of financial condition and operations, not indicating any immediate adverse events.

Key Players & Entities

• CareDx, Inc. (company) — Registrant
• Delaware (company) — State of Incorporation
• 94-3316839 (dollar_amount) — IRS Employer Identification No.
• February 28, 2024 (date) — Date of Report
• 8000 Marina Boulevard, Brisbane, California 94005 (company) — Principal Executive Offices

FAQ

Key Financial Figures

• $0.001 — nge on which registered) Common Stock, $0.001 Par Value CDNA The Nasdaq Stock Market

Filing Documents

• cdna-20240228.htm (8-K) — 31KB
• cdna-20240228_earningsrele.htm (EX-99.1) — 334KB
• a190801cdnaq2fy19earn_imag.gif (GRAPHIC) — 13KB
• 0001217234-24-000032.txt ( ) — 524KB
• cdna-20240228.xsd (EX-101.SCH) — 2KB
• cdna-20240228_lab.xml (EX-101.LAB) — 23KB
• cdna-20240228_pre.xml (EX-101.PRE) — 12KB
• cdna-20240228_htm.xml (XML) — 3KB

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On February 28, 2024, CareDx, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended December 31, 2023. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 2.02, including the press release attached hereto as Exhibit 99.1 is intended to be furnished under Item 2.02 and Item 9.01 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. The Company is posting an updated corporate presentation (the "Corporate Presentation") on its website. The Corporate Presentation is current as of February 28, 2024, and the Company disclaims any obligation to update this material in the future.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release issued by CareDx, Inc., dated February 28, 2024. 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 28, 2024 CAREDX, INC. By: /s/ Abhishek Jain Abhishek Jain Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR